Oracle shares surge 3.10% in pre-market trading as renewed investor confidence ahead of earnings report

Oracle shares surged 3.103% in pre-market trading on January 13, 2026, signaling renewed investor confidence ahead of its earnings report.

Jefferies reaffirmed a Buy rating with a $400 price target, citing Oracle’s strategic positioning in AI infrastructure and cloud growth. Analysts highlighted the company’s data center expansions, including a 1.2 GW facility in Abilene and a 1.4 GW partnership with OpenAI, as key catalysts for long-term revenue potential. Goldman Sachs also upgraded Oracle to Buy with a $240 target, emphasizing its competitive edge in AI compute workloads and manageable debt trajectory.

Positive momentum was further fueled by Oracle’s recent healthcare and retail product launches, including an AI-driven clinical solution for Community Memorial Hospital and a supply chain collaboration tool for retailers. These developments underscore Oracle’s ability to secure enterprise contracts and expand its AI/cloud monetization narrative. However, high-profile investor Michael Burry’s short position on Oracle—highlighting $95 billion in data-center debt—introduced near-term downside risks amid sector-wide scrutiny of AI valuation multiples.

The stock’s upward trajectory reflects a mix of institutional optimism and tangible business progress, though investors remain cautious about execution risks in scaling infrastructure profitably.